Surveillance of antimicrobial resistance in Lebanese hospitals: Retrospective nationwide compiled data

International Journal of Infectious Diseases

Volumn 46, Issue , 2016, Pages 64-70

  Chamoun, Kamal ^a   Farah, Maya ^a   Araj, Georges ^b   Daoud, Ziad ^c   Moghnieh, Rima ⁱ   Salameh, Pascale ^d   Saade, Danielle ^e   Mokhbat, Jacques ^a   Abboud, Emme ^f   Hamze, Monzer ^g   Abboud, Edmond ^h   Jisr, Tamima ⁱ   Haddad, Antoine ^j   Feghali, Rita ^k   Azar, Nadim ^l   El Zaatari, Mohammad ^m   Chedid, Marwan ⁿ   Haddad, Christian ^o   Zouain Dib Nehme, Mireille ^p   Barakat, Angelique ^q   Husni, Rola ^a   more..

^a RIZK HOSPITAL   (Lebanon)

^b AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^c UNIVERSITY OF BALAMAND   (Lebanon)

^d LEBANESE AMERICAN UNIVERSITY   (Lebanon)

^e MINISTRY OF PUBLIC HEALTH   (Lebanon)

^f MOUNT LEBANON HOSPITAL   (Lebanon)

^g Nini Hospital   (Lebanon)

^h The Middle East Institute of Health   (Lebanon)

ⁱ MAKASSED GENERAL HOSPITAL   (Lebanon)

^j Sacre Coeur Hospital Baabda   (Lebanon)

^k RAFIC HARIRI UNIVERSITY HOSPITAL   (Lebanon)

^l SAINT JOSEPH UNIVERSITY   (Lebanon)

^m Hammoud Hospital   (Lebanon)

ⁿ Mazloum Hospital   (Lebanon)

^o Notre Dame des Secours University Hospital Center   (Lebanon)

^p Abou Jaoude Hospital   (Lebanon)

^q Bellevue Hospital   (Lebanon)

more..

Author keywords

Gram negative bacteria; Gram positive bacteria; Lebanon; Resistance; Susceptibility

Indexed keywords

AMPICILLIN; CEFTRIAXONE; CLINDAMYCIN; COLISTIN; ERYTHROMYCIN; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; LEVOFLOXACIN; OXACILLIN; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; TEICOPLANIN; TIGECYCLINE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ACINETOBACTER; ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC RESISTANCE; ARTICLE; CITROBACTER; COAGULASE NEGATIVE STAPHYLOCOCCUS; ENTEROBACTER; ENTEROCOCCUS; ESCHERICHIA COLI; HAEMOPHILUS INFLUENZAE; HUMAN; KLEBSIELLA; LEBANESE; LEBANON; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORAXELLA CATARRHALIS; MORGANELLA MORGANII; NONHUMAN; PREVALENCE; PROTEUS; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; SALMONELLA; SERRATIA; SHIGELLA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; VANCOMYCIN RESISTANT ENTEROCOCCUS; BACTERIAL INFECTIONS; BACTERIUM; CLASSIFICATION; DRUG EFFECTS; HOSPITAL; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; STATISTICS AND NUMERICAL DATA;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; DRUG RESISTANCE, BACTERIAL; HOSPITALS; HUMANS; LEBANON; MICROBIAL SENSITIVITY TESTS; RETROSPECTIVE STUDIES;

EID: 84963878370     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2016.03.010     Document Type: Article

References (27)

1. Centers for Disease Control and Prevention (CDC) Antibiotic resistance threats in the United States 2013, CDC, Atlanta, GA.
2. Zowawi H.M., Balkhy H.H., Walsh T.R., Paterson D.L. β-Lactamase production in key Gram-negative pathogen isolates from the Arabian Peninsula. Clin Microbiol Rev 2013, 26:361-380.
3. Sosa A., Byarugaba D., Amabile-Cuevas C., Hsueh P., Kariuki S., Okeke I. Antimicrobial Resistance in Developing Countries 2010, Springer, New York, NY.
4. Skov R., Larsen A.R., Kearns A., Holmes M., Teale C., Edwards G., et al. Phenotypic detection of mecC-MRSA: cefoxitin is more reliable than oxacillin. J. Antimicrob Chemother 2014, 69:133-135.
5. Drieux L., Brossier F., Sougakoff W., Jarlier V. Phenotypic detection of extended-spectrum β-lactamase production in Enterobacteriaceae: review and bench guide. Clin Microbiol Infect 2008, 14:90-103.
6. Araj G.F., Uwaydah M.M., Alami S.Y. Antimicrobial susceptibility patterns of bacterial isolates at the American University Medical Center in Lebanon. Diagn Microbiol Infect Dis 1994, 20:151-158.
7. Badawi H., Saad Diab M., El Said M. Impact of antibiotic policy in a tertiary care research institute hospital in Egypt: three years experience. Int J Infect Contr 2007, 3. 10.3396/03-01-10-07.
8. Nimmo G.R., Pearson J.C., Collignon P.J., Christiansen K.J., Coombs G.W., Bell J.M., et al. Australian Group on Antimicrobial Resistance. Antimicrobial susceptibility of Staphylococcus aureus isolated from hospital inpatients, 2009: report from the Australian Group on Antimicrobial Resistance. Commun Dis Intell Q Rep 2011, 35:237-243.
9. Borg M.A., de Kraker M., Scicluna E., van de Sande-Bruinsma N., Tiemersma E., Monen J., et al. ARMed Project Members and Collaborators. Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in invasive isolates from southern and eastern Mediterranean countries. J Antimicrob Chemother 2007, 60:1310-1315.
10. Araj G.F., Avedissian A.Z., Ayyash N.S., Bey H.A., El Asmar R.G., Hammoud R.Z., et al. A reflection on bacterial resistance to antimicrobial agents at a major tertiary care center in Lebanon over a decade. J Med Liban 2012, 60:125-135.
11. Uwaydah M., Jradeh M., Shihab Z. Antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Lebanon. J Antimicrob Chemother 1996, 38:283-286.
12. Shaar T.J., Al-Hajjar R. Antimicrobial susceptibility patterns of bacteria at the Makassed General Hospital in Lebanon. Int J Antimicrob Agents 2000, 14:161-164.
13. Daoud Z., Cocozaki A., Hakime N. Antimicrobial susceptibility patterns of Haemophilus influenzae and Streptococcus pneumoniae isolates in a Beirut general university hospital between 2000 and 2004. Clin Microbiol Infect 2006, 12:86-90.
14. Daoud Z1, Kourani M., Saab R., Nader M.A., Hajjar M. Resistance of Streptococcus pneumoniae isolated from Lebanese patients between 2005 and 2009. Rev Esp Quimioter 2011, 24:84-90.
15. Borg M.A., Tiemersma E., Scicluna E., van de Sande-Bruinsma N., de Kraker M., Monen J., et al. Prevalence of penicillin and erythromycin resistance among invasive Streptococcus pneumoniae isolates reported by laboratories in the southern and eastern Mediterranean region. Clin Microbiol Infect Dis 2009, 15:232-237. ARMed Project members and collaborators.
16. Eid A.J., Berbari E.F. The emergence of antibiotic resistance in Lebanon: reality check and call for action. J Med Liban 2013, 61:125-126.
17. Centers for Disease Control and Prevention Effects of new penicillin susceptibility breakpoints for Streptococcus pneumoniae-United States, 2006-2007. Morb Mortal Wkly Rep 2008, 57:1353-1355.
18. Matar G.M., Jaafar R., Sabra A., Hart C.A., Corkill J.E., Dbaibo G.S., et al. First detection and sequence analysis of the bla-CTX-M-15 gene in Lebanese isolates of extended-spectrum-β-lactamase-producing Shigella sonnei. Ann Trop Med Parasitol 2007, 101:511-517.
19. Sabra A.H., Araj G.F., Kattar M.M., Abi-Rached R.Y., Khairallah M.T., Klena J.D., et al. Molecular characteristics of ESBL-producing Shigella sonnei isolates from patients with bacillary dysentery in Lebanon. J Infect Dev Ctries 2009, 3:300-305.
20. Daoud Z., Hakime N. Prevalence and susceptibility patterns of extended-spectrum betalactamase-producing Escherichia coli and Klebsiella pneumoniae in a general university hospital in Beirut, Lebanon. Rev Esp Quimioter 2003, 16:233-238.
21. Daoud Z., Afif C. Escherichia coli isolated from urinary tract infections of Lebanese patients between 2000 and 2009: epidemiology and profiles of resistance. Chemother Res Pract 2011, 2011:6. Article ID 218431. 10.1155/2011/218431.
22. Zarrilli R., Vitale D., Di Popolo A., Bagattini M., Daoud Z., Khan A.U., et al. A plasmid-borne blaOXA-58 gene confers imipenem resistance to Acinetobacter baumannii isolates from a Lebanese hospital. Antimicrob Agents Chemother 2008, 52:4115-4120.
23. Giannouli M., Tomasone F., Agodi A., Vahaboglu H., Daoud Z., Triassi M., et al. Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii strains in intensive care units of multiple Mediterranean hospitals. J Antimicrob Chemother 2009, 63:828-830.
24. Mouawad R., Afif C., Azar E., Dahdouh E., Masri K., Irani J., et al. Effect of antibiotic consumption on resistance of Pseudomonas aeruginosa isolated from Lebanese patients with emphasis on MBL production. Adv Microbiol 2013, 3:382-388.
25. Hombach M., Bloemberg G.V., Böttger E.C. Effects of clinical breakpoint changes in CLSI guidelines 2010/2011 and EUCAST guidelines 2011 on antibiotic susceptibility test reporting of Gram-negative bacilli. J Antimicrob Chemother 2012, 67:622-632. Epub 2011 Dec 13. 10.1093/jac/dkr524.
26. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing: twentieth informational supplement M100-S20 2010, CLSI, Wayne, PA.
27. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing: twenty-first informational supplement M100-S21 2011, CLSI, Wayne, PA.